Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02756754
NA

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

Sponsor: University Hospital, Toulouse

View on ClinicalTrials.gov

Summary

The aim of the study is to evaluate the novel use of adrenal radiofrequency ablation on a prospective cohort of patients with primary aldosteronism and unilateral adrenal adenoma concerning the efficacy on blood pressure control. The safety of the procedure is one of the secondary outcomes.

Official title: Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism: Evaluation of the Blood Pressure Control and of Its Safety.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

31

Start Date

2016-11-07

Completion Date

2019-05-10

Last Updated

2026-05-04

Healthy Volunteers

No

Interventions

DEVICE

Radiofrequency ablation

The radiofrequency system will be used as the RFA generator device standard cycle of ablation will be applied in the patient. During RFA, blood pressure, pulse and oxygen saturation will be continuously monitored.

Locations (2)

CHU Bordeaux

Bordeaux, France

CHU de Toulouse

Toulouse, France